- Home
- GLSI vs KRMD Comparison
GLSI vs KRMD Comparison
Compare GLSI & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- KRMD
- Stock Information
- Founded
- GLSI 2006
- KRMD 1980
- Country
- GLSI United States
- KRMD United States
- Employees
- GLSI N/A
- KRMD N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- KRMD Medical/Dental Instruments
- Sector
- GLSI Health Care
- KRMD Health Care
- Exchange
- GLSI Nasdaq
- KRMD Nasdaq
- Market Cap
- GLSI 134.6M
- KRMD 134.3M
- IPO Year
- GLSI 2020
- KRMD N/A
- Fundamental
- Price
- GLSI $11.65
- KRMD $4.32
- Analyst Decision
- GLSI Strong Buy
- KRMD Strong Buy
- Analyst Count
- GLSI 1
- KRMD 4
- Target Price
- GLSI $39.00
- KRMD $4.63
- AVG Volume (30 Days)
- GLSI 45.8K
- KRMD 128.3K
- Earning Date
- GLSI 08-14-2025
- KRMD 08-06-2025
- Dividend Yield
- GLSI N/A
- KRMD N/A
- EPS Growth
- GLSI N/A
- KRMD N/A
- EPS
- GLSI N/A
- KRMD N/A
- Revenue
- GLSI N/A
- KRMD $36,848,451.00
- Revenue This Year
- GLSI N/A
- KRMD $21.08
- Revenue Next Year
- GLSI N/A
- KRMD $16.37
- P/E Ratio
- GLSI N/A
- KRMD N/A
- Revenue Growth
- GLSI N/A
- KRMD 19.57
- 52 Week Low
- GLSI $8.06
- KRMD $1.86
- 52 Week High
- GLSI $16.50
- KRMD $5.05
- Technical
- Relative Strength Index (RSI)
- GLSI 53.04
- KRMD 62.89
- Support Level
- GLSI $11.51
- KRMD $4.12
- Resistance Level
- GLSI $12.07
- KRMD $4.42
- Average True Range (ATR)
- GLSI 0.58
- KRMD 0.18
- MACD
- GLSI -0.07
- KRMD 0.01
- Stochastic Oscillator
- GLSI 31.86
- KRMD 71.70
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).